About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Peptide Synthesis Service
Oligonucleotide Synthesis
Cosmetic Peptides
GMP Manufacturing
GMP Production Capacity
GMP Compliance & Certification
Leuprorelin Acetate
Triptorelin Acetate
Triptorelin Pamoate
Goserelin Acetate
Cetrorelix Acetate
Exenatide Acetate
Semaglutide
Terlipressin Acetate
Teduglutide
Linaclotide
Difelikefalin
Resources Center
FAQ
White Paper
Video
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
WHAT ARE YOU LOOKING FOR?
Home
About Us
About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Resources Center
Resources Center
FAQ
White Paper
Video
News
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
Email Us
Search
Search
Home
Catalog Peptides
PAR Peptides and Analogs
PAR Peptides and Analogs
PARP-001A
PAR-2 (1-6) amide (human) (scrambled)
Leu-Ser-Ile-Gly-Lys-Val-NH2 Trifluoroacetate salt
PARP-002A
T1
Met-Ser-Arg-Pro-Ala-Cys-Pro-Asn-Asp-Lys-Tyr-Glu
PARP-002B
T1
Met-Ser-Arg-Pro-Ala-Cys-Pro-Asn-Asp-Lys-Tyr-Glu
PARP-003A
PAR-1 (1-6) (mouse, rat)
H-Ser-Phe-Phe-Leu-Arg-Asn-OH Trifluoroacetate salt
PARP-003B
PAR-1 (1-6) (mouse, rat)
H-Ser-Phe-Phe-Leu-Arg-Asn-OH Trifluoroacetate salt
PARP-004A
(Phe1,Ser2,Tyr6)-PAR-1 (1-6) amide (human)
Phe-Ser-Leu-Leu-Arg-Tyr-NH2 Trifluoroacetate salt
PARP-004B
(Phe1,Ser2,Tyr6)-PAR-1 (1-6) amide (human)
Phe-Ser-Leu-Leu-Arg-Tyr-NH2 Trifluoroacetate salt
PARP-005A
PAR-2 (1-6) (mouse, rat)
Ser-Leu-Ile-Gly-Arg-Leu-OH Trifluoroacetate salt
PARP-005B
PAR-2 (1-6) (mouse, rat)
Ser-Leu-Ile-Gly-Arg-Leu-OH Trifluoroacetate salt
PARP-006A
PAR-2 (1-6) amide (mouse, rat)
Ser-Leu-Ile-Gly-Arg-Leu-NH2 Trifluoroacetate salt
PARP-006B
PAR-2 (1-6) amide (mouse, rat)
Ser-Leu-Ile-Gly-Arg-Leu-NH2 Trifluoroacetate salt
PARP-007A
PAR-3 (1-6) (human)
H-Thr-Phe-Arg-Gly-Ala-Pro-OH Trifluoroacetate salt
PARP-008A
PAR-3 (1-6) amide (human)
Thr-Phe-Arg-Gly-Ala-Pro-NH2 Trifluoroacetate salt
PARP-008B
PAR-3 (1-6) amide (human)
Thr-Phe-Arg-Gly-Ala-Pro-NH2 Trifluoroacetate salt
PARP-009A
PAR-3 (1-6) amide (mouse)
Ser-Phe-Asn-Gly-Gly-Pro-NH2 Trifluoroacetate salt
PARP-009B
PAR-3 (1-6) amide (mouse)
Ser-Phe-Asn-Gly-Gly-Pro-NH2 Trifluoroacetate salt
PARP-010A
PAR-4 (1-6) (human)
H-Gly-Tyr-Pro-Gly-Gln-Val-OH Trifluoroacetate salt
PARP-010B
PAR-4 (1-6) (human)
H-Gly-Tyr-Pro-Gly-Gln-Val-OH Trifluoroacetate salt
PARP-011A
PAR-4 (1-6) (mouse)
H-Gly-Tyr-Pro-Gly-Lys-Phe-OH Trifluoroacetate salt
PARP-012A
(Ala1)-PAR-4 (1-6) (mouse)
H-Ala-Tyr-Pro-Gly-Lys-Phe-OH Trifluoroacetate salt
PARP-012B
(Ala1)-PAR-4 (1-6) (mouse)
H-Ala-Tyr-Pro-Gly-Lys-Phe-OH Trifluoroacetate salt
PARP-013A
PAR-4 (1-6) amide (human)
H-Gly-Tyr-Pro-Gly-Gln-Val-NH2 Trifluoroacetate salt
PARP-013B
PAR-4 (1-6) amide (human)
H-Gly-Tyr-Pro-Gly-Gln-Val-NH2 Trifluoroacetate salt
PARP-014A
PAR-4 (1-6) amide (mouse)
H-Gly-Tyr-Pro-Gly-Lys-Phe-NH2 Trifluoroacetate salt
PARP-014B
PAR-4 (1-6) amide (mouse)
H-Gly-Tyr-Pro-Gly-Lys-Phe-NH2 Trifluoroacetate salt
PARP-015A
(Ala1)-PAR-4 (1-6) amide (mouse)
H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2 Trifluoroacetate salt
PARP-015B
(Ala1)-PAR-4 (1-6) amide (mouse)
H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2 Trifluoroacetate salt
PARP-016A
TRAP-5
H-Ser-Phe-Leu-Leu-Arg-OH Trifluoroacetate salt
PARP-016V
TRAP-5
H-Ser-Phe-Leu-Leu-Arg-OH Trifluoroacetate salt
PARP-017A
TRAP-5 amide
Ser-Phe-Leu-Leu-Arg-NH2 Trifluoroacetate salt
PARP-018A
TRAP-6
Ser-Phe-Leu-Leu-Arg-Asn-OH Trifluoroacetate salt
PARP-018B
TRAP-6
Ser-Phe-Leu-Leu-Arg-Asn-OH Trifluoroacetate salt
PARP-019A
TRAP-6 amide
Ser-Phe-Leu-Leu-Arg-Asn-NH2 Trifluoroacetate salt
PARP-019B
TRAP-6 amide
Ser-Phe-Leu-Leu-Arg-Asn-NH2 Trifluoroacetate salt
PARP-020A
TRAP-6 (2-6)
H-Phe-Leu-Leu-Arg-Asn-OH Trifluoroacetate salt
PARP-020B
TRAP-6 (2-6)
H-Phe-Leu-Leu-Arg-Asn-OH Trifluoroacetate salt
PARP-021A
TRAP-7
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-OH Trifluoroacetate salt
PARP-021B
TRAP-7
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-OH Trifluoroacetate salt
PARP-022A
TRAP-14
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH Trifluoroacetate salt
PARP-022B
TRAP-14
H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH Trifluoroacetate salt
PARP-023A
TRAP-14 amide
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-NH2 Trifluoroacetate salt
PARP-023B
TRAP-14 amide
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-NH2 Trifluoroacetate salt
PARP-024A
PAR - 1 Agonist;Protease - Activated Receptor - 1
Thr-Phe-Leu-Leu-Arg-Asn
PARP-025A
Protease - Activated Receptor - 1, PAR - 1 Agonist, amide
Thr-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-NH2
Chinese Peptide Updates
30
Nov
2023
Emerging Trends in CGMP Peptide Manufacturing for Therapeutic Breakthroughs
Understanding the Importance of CGMP Peptides in Biopharmaceuticals
Nov 16, 2023
Exhibition review | Chinese Peptide company attended the 3rd China Polypeptide Industry Conference
Oct 11, 2023
The 8th CPC Symposiun on Peptide and Oligonucleotide Therapeutics was successfully concluded
Oct 10, 2023
86-571-86737011
Your browser does not support VBScript!